미국 · 보도자료 · LB Pharmaceuticals Inc · 2026-10-06 12:00
10월 27일 R&D 데이 개최, 조현병 치료제 LB-102 개발 현황 발표
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced that it will host an in-person and virtual R&D Day on Tuesday, October 27, 2026, with presentations b
LB Pharmaceuticals Inc 다른 공시·급등 이유 보기 · GK의 공시레이더 — 미국·한국 실시간 공시
